{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:23:27Z","timestamp":1788985407557,"version":"build-2803163510"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"DOI":"10.12788\/cutis.1142","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T20:47:06Z","timestamp":1736887626000},"source":"Crossref","is-referenced-by-count":3,"title":["Successful Treatment of Severe Dystrophic Nail Psoriasis With Deucravacitinib"],"prefix":"10.12788","volume":"114","author":[{"given":"Jennifer","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5043","container-title":["Cutis"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/CT114006196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T20:47:06Z","timestamp":1736887626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/dermatology\/article\/271786\/psoriasis\/successful-treatment-severe-dystrophic-nail-psoriasis-deucravacitinib"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12,1]]},"published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.12788\/cutis.1142","relation":{},"subject":[],"published":{"date-parts":[[2024,12,1]]}}}